Autoimmunity and inflammation are independent of class II transactivator type PIV-dependent class II major histocompatibility complex expression in peripheral tissues during collagen-induced arthritis.

OBJECTIVE To determine the regulation of class II major histocompatibility complex (MHC) expression in fibroblast-like synoviocytes (FLS) in order to investigate their role as nonprofessional antigen-presenting cells in collagen-induced arthritis (CIA). METHODS Expression of class II MHC, class II MHC transactivator (CIITA), and Ciita isoforms PI, PIII, and PIV was examined by real-time quantitative polymerase chain reaction, immunohistochemistry, and flow cytometry in human synovial tissues, arthritic mouse joints, and human and murine FLS. CIA was induced in mice in which isoform PIV of Ciita was knocked out (PIV(-/-) ), in PIV(-/-) mice transgenic for CIITA in the thymus (K14 CIITA), and in their control littermates. RESULTS HLA-DRA, total CIITA, and CIITA PIII messenger RNA levels were significantly increased in synovial tissue samples from patients with rheumatoid arthritis compared with the levels in tissue from patients with osteoarthritis. Human FLS expressed surface class II MHC via CIITA PIII and PIV, while class II MHC expression in murine FLS was entirely mediated by PIV. Mice with a targeted deletion of CIITA PIV lack CD4+ T cells and were protected against CIA. The expression of CIITA was restored in the thymus of PIV(-/-) K14 CIITA-transgenic mice, which had a normal CD4+ T cell repertoire and normal surface levels of class II MHC on professional antigen-presenting cells, but did not induce class II MHC on FLS. Synovial inflammation and immune responses against type II collagen were similar in PIV(-/-) K14 CIITA-transgenic mice and control mice with CIA, but bone erosion was significantly reduced in the absence of PIV. CONCLUSION Overexpression of class II MHC is tightly correlated with CIITA expression in arthritic synovium and in FLS. Selective targeting of Ciita PIV in peripheral tissues abrogates class II MHC expression by murine FLS but does not protect against inflammation and autoimmune responses in CIA.

[1]  U. Müller-Ladner,et al.  Rheumatoid arthritis progression mediated by activated synovial fibroblasts. , 2010, Trends in molecular medicine.

[2]  C. Gabay,et al.  Enhanced Th1 and Th17 responses and arthritis severity in mice with a deficiency of myeloid cell-specific interleukin-1 receptor antagonist. , 2010, Arthritis and rheumatism.

[3]  M. Brenner,et al.  Fibroblast‐like synoviocytes in inflammatory arthritis pathology: the emerging role of cadherin‐11 , 2010, Immunological reviews.

[4]  G. Firestein,et al.  Fibroblast‐like synoviocytes: key effector cells in rheumatoid arthritis , 2010, Immunological reviews.

[5]  Dirk E. Smith,et al.  Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis. , 2009, Arthritis and rheumatism.

[6]  R. Écochard,et al.  Genome-Wide Comparison between IL-17A- and IL-17F-Induced Effects in Human Rheumatoid Arthritis Synoviocytes1 , 2009, The Journal of Immunology.

[7]  W. Reith,et al.  Autoantigen-specific interactions with CD4+ thymocytes control mature medullary thymic epithelial cell cellularity. , 2008, Immunity.

[8]  S. Gay,et al.  The role of resident synovial cells in destructive arthritis. , 2008, Best practice & research. Clinical rheumatology.

[9]  Peter T. White,et al.  Interactions of T Cells with Fibroblast-Like Synoviocytes: Role of the B7 Family Costimulatory Ligand B7-H31 , 2008, The Journal of Immunology.

[10]  R. Romieu-Mourez,et al.  Regulation of MHC Class II Expression and Antigen Processing in Murine and Human Mesenchymal Stromal Cells by IFN-γ, TGF-β, and Cell Density1 , 2007, The Journal of Immunology.

[11]  Michael J. Davis,et al.  Presentation of arthritogenic peptide to antigen-specific T cells by fibroblast-like synoviocytes. , 2007, Arthritis and rheumatism.

[12]  P. J. van den Elsen,et al.  Constitutive and IFNgamma-induced activation of MHC2TA promoter type III in human melanoma cell lines is governed by separate regulatory elements within the PIII upstream regulatory region. , 2007, Molecular immunology.

[13]  R. Zinkernagel,et al.  Functional CD8+ but not CD4+ T cell responses develop independent of thymic epithelial MHC , 2006, Proceedings of the National Academy of Sciences.

[14]  B. Peterlin,et al.  Aberrant MHC class II expression in mouse joints leads to arthritis with extraarticular manifestations similar to rheumatoid arthritis , 2006, Proceedings of the National Academy of Sciences.

[15]  C. Gabay,et al.  The new IL-1 family member IL-1F8 stimulates production of inflammatory mediators by synovial fibroblasts and articular chondrocytes , 2006, Arthritis research & therapy.

[16]  P. Klous,et al.  Lack of MHC-II expression in activated mouse T cells correlates with DNA methylation at the CIITA-PIII region , 2005, Immunogenetics.

[17]  W. Reith,et al.  Regulation of MHC class II gene expression by the class II transactivator , 2005, Nature Reviews Immunology.

[18]  C. Gabay,et al.  Assessment of the efficacy of different statins in murine collagen-induced arthritis. , 2004, Arthritis and rheumatism.

[19]  W. Reith,et al.  MHC class II expression is differentially regulated in plasmacytoid and conventional dendritic cells , 2004, Nature Immunology.

[20]  W. Reith,et al.  Promoter IV of the Class II transactivator gene is essential for positive selection of CD4+ T cells , 2002 .

[21]  N. Zvaifler,et al.  Inflammation is preceded by tumor necrosis factor-dependent infiltration of mesenchymal cells in experimental arthritis. , 2002, Arthritis and rheumatism.

[22]  Y. Iwakura,et al.  Suppression of autoimmune arthritis in interleukin-1-deficient mice in which T cell activation is impaired due to low levels of CD40 ligand and OX40 expression on T cells. , 2002, Arthritis and rheumatism.

[23]  W. Reith,et al.  Selective Abrogation of Major Histocompatibility Complex Class II Expression on Extrahematopoietic Cells in Mice Lacking Promoter IV of the Class II Transactivator Gene , 2001, The Journal of experimental medicine.

[24]  W. Reith,et al.  Maturation of Dendritic Cells Is Accompanied by Rapid Transcriptional Silencing of Class II Transactivator (Ciita) Expression , 2001, The Journal of experimental medicine.

[25]  N. Williams,et al.  The genetic and immunopathological processes underlying collagen‐induced arthritis , 2001, Immunology.

[26]  Frank Emmrich,et al.  Isolation and characterization of rheumatoid arthritis synovial fibroblasts from primary culture — primary culture cells markedly differ from fourth-passage cells , 2000, Arthritis research.

[27]  G. Panayi,et al.  Lack of CD80 expression by fibroblast-like synoviocytes leading to anergy in T lymphocytes. , 2000, Arthritis and rheumatism.

[28]  K. Okada,et al.  HLA-DR expression of synovium and correlation with clinical features of patients with rheumatoid arthritis. , 2000, The Tohoku journal of experimental medicine.

[29]  D. Elewaut,et al.  Needle Arthroscopy of the Knee with Synovial Biopsy Sampling: Technical Experience in 150 Patients , 1999, Clinical Rheumatology.

[30]  B. Mach,et al.  Quantitative control of MHC class II expression by the transactivator CIITA , 1998, European journal of immunology.

[31]  J. Ting,et al.  Identification of Distinct Regions of 5′ Flanking DNA That Mediate Constitutive, IFN-γ, STAT1, and TGF-β-Regulated Expression of the Class II Transactivator Gene , 1998, The Journal of Immunology.

[32]  B. Mach,et al.  Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA , 1997, The EMBO journal.

[33]  M. Kraft,et al.  Synovial fibroblasts as accessory cells for staphylococcal enterotoxin-mediated T-cell activation. , 1995, Immunology.

[34]  A. Boots,et al.  Antigen-presenting capacity of rheumatoid synovial fibroblasts. , 1994, Immunology.

[35]  G. Firestein,et al.  Cytokines in chronic inflammatory arthritis. V. Mutual antagonism between interferon-gamma and tumor necrosis factor-alpha on HLA-DR expression, proliferation, collagenase production, and granulocyte macrophage colony-stimulating factor production by rheumatoid arthritis synoviocytes. , 1990, The Journal of clinical investigation.

[36]  F. Arnett.  Revised criteria for the classification of rheumatoid arthritis. , 1990, Orthopedic nursing.

[37]  W. J. Johnson,et al.  Inhibition of IFN-gamma-induced Ia antigen expression on synovial fibroblasts by IL-1. , 1989, Journal of immunology.

[38]  M. Liang,et al.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. , 1988, Arthritis and rheumatism.

[39]  R. Winchester,et al.  Differential expression of Ia antigens by rheumatoid synovial lining cells. , 1987, The Journal of clinical investigation.